Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
David A. Knorr(Memorial Sloan Kettering Cancer Center), Dan S. Kaufman(University of California San Diego)
Cited by 413
Related Papers
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
|Cell stem cell|2018|980
Cardiac Repair in a Porcine Model of Acute Myocardial Infarction with Human Induced Pluripotent Stem Cell-Derived Cardiovascular Cells
|Cell stem cell|2014|450
Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis
|Stem Cells|2021|54
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
|Cancer Immunology Research|2023|31
Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells
|Scientific Reports|2016|21